(Q33275237)

25 July 2017

title

MGMT promoter methylation status in clival chordoma (English)

1 reference

25 July 2017

0 references

Diego Mazzatenta

0 references

Luca Morandi

0 references

Gianluca Marucci

0 references

Maria Pia Foschini

0 references

Giorgio Frank

1 reference

25 July 2017

Ernesto Pasquini

series ordinal

1 reference

25 July 2017

publication date

26 April 2014

1 reference

Journal of Neuro-Oncology

25 July 2017

published in

1 reference

25 July 2017

volume

118

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

271-276

1 reference

Chordoma: current concepts, management, and future directions

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Molecular characterization of putative chordoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Chordoma: the nonsarcoma primary bone tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Chordoma characterization of significant changes of the DNA methylation pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Current therapeutic options and novel molecular markers in skull base chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Imatinib mesylate in chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Phase II study of imatinib in advanced chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24771251

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24771251

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The endoscopic transnasal transsphenoidal approach for the treatment of cranial base chordomas and chondrosarcomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24771251

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-014-1445-Y

1 reference

Dimensions Publication ID

25 July 2017

1036243040

0 references

1 reference